A detailed history of Stifel Financial Corp transactions in Illumina, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 261,154 shares of ILMN stock, worth $34.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
261,154
Previous 131,532 98.55%
Holding current value
$34.4 Million
Previous $13.7 Million 148.04%
% of portfolio
0.04%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $13.6 Million - $17.6 Million
129,622 Added 98.55%
261,154 $34.1 Million
Q2 2024

Aug 13, 2024

BUY
$101.05 - $133.57 $2.49 Million - $3.3 Million
24,676 Added 23.09%
131,532 $13.7 Million
Q1 2024

May 13, 2024

BUY
$127.73 - $147.2 $6.95 Million - $8.01 Million
54,409 Added 103.74%
106,856 $14.7 Million
Q4 2023

Feb 12, 2024

BUY
$92.79 - $142.53 $303,330 - $465,930
3,269 Added 6.65%
52,447 $7.3 Million
Q3 2023

Nov 13, 2023

BUY
$128.91 - $192.44 $1.55 Million - $2.32 Million
12,055 Added 32.47%
49,178 $6.75 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $1.56 Million - $1.98 Million
-8,489 Reduced 18.61%
37,123 $6.96 Million
Q1 2023

May 12, 2023

BUY
$193.75 - $232.55 $693,431 - $832,296
3,579 Added 8.51%
45,612 $10.6 Million
Q4 2022

Feb 13, 2023

BUY
$187.24 - $242.74 $719,376 - $932,607
3,842 Added 10.06%
42,033 $8.5 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $294,024 - $377,322
-1,659 Reduced 4.16%
38,191 $7.29 Million
Q2 2022

Aug 15, 2022

BUY
$181.58 - $368.0 $1.16 Million - $2.34 Million
6,371 Added 19.03%
39,850 $7.35 Million
Q1 2022

May 13, 2022

SELL
$303.87 - $423.8 $1.35 Million - $1.89 Million
-4,454 Reduced 11.74%
33,479 $11.7 Million
Q4 2021

Feb 14, 2022

SELL
$347.28 - $421.83 $587,945 - $714,158
-1,693 Reduced 4.27%
37,933 $14.4 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $1.65 Million - $2.13 Million
4,064 Added 11.43%
39,626 $16.1 Million
Q2 2021

Aug 13, 2021

SELL
$372.84 - $481.5 $554,413 - $715,990
-1,487 Reduced 4.01%
35,562 $16.8 Million
Q1 2021

May 14, 2021

BUY
$361.28 - $504.76 $4.34 Million - $6.06 Million
12,015 Added 47.99%
37,049 $14.2 Million
Q4 2020

Feb 12, 2021

SELL
$292.7 - $370.96 $3.26 Million - $4.13 Million
-11,140 Reduced 30.8%
25,034 $9.26 Million
Q3 2020

Nov 16, 2020

BUY
$268.51 - $400.74 $1.04 Million - $1.55 Million
3,868 Added 11.97%
36,174 $11.2 Million
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $827,852 - $1.2 Million
3,228 Added 11.1%
32,306 $12 Million
Q1 2020

May 14, 2020

SELL
$209.2 - $335.53 $12.3 Million - $19.8 Million
-58,976 Reduced 66.98%
29,078 $7.94 Million
Q4 2019

Feb 13, 2020

BUY
$288.29 - $335.49 $17.8 Million - $20.7 Million
61,837 Added 235.87%
88,054 $29.2 Million
Q3 2019

Nov 19, 2019

BUY
$266.84 - $378.23 $533 - $756
2 Added 0.01%
26,217 $7.97 Million
Q3 2019

Nov 13, 2019

SELL
$266.84 - $378.23 $16.8 Million - $23.7 Million
-62,777 Reduced 70.54%
26,215 $7.97 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $21.1 Million - $25.8 Million
70,034 Added 369.42%
88,992 $32.8 Million
Q1 2019

May 14, 2019

SELL
$272.57 - $321.18 $15.9 Million - $18.7 Million
-58,234 Reduced 75.44%
18,958 $5.89 Million
Q4 2018

Feb 13, 2019

BUY
$272.46 - $366.54 $490,427 - $659,772
1,800 Added 2.39%
77,192 $23.1 Million
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $1.93 Million - $2.54 Million
6,925 Added 10.11%
75,392 $27.7 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $1.18 Million - $1.52 Million
5,191 Added 8.2%
68,467 $19.1 Million
Q1 2018

May 11, 2018

BUY
$209.54 - $253.91 $325,625 - $394,576
1,554 Added 2.52%
63,276 $15 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $224,879 - $255,793
1,112 Added 1.83%
61,722 $13.5 Million
Q3 2017

Nov 13, 2017

BUY
$172.3 - $213.93 $10.4 Million - $13 Million
60,610
60,610 $0

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.